Swiss Patients Now Have Gentler Option to Treat Brain Tumors and Other Brain Disorders

Switzerland's Centre Hospitalier Universitaire Vaudois launches Gamma Knife surgery program

Lausanne Switzerland — Thursday, October 14, 2010

Centre Hospitalier Universitaire Vaudois (CHUV), a major university hospital in Lausanne, Switzerland is the first to use Leksell Gamma Knife® Perfexion™ in the country. Since July, a multidisciplinary team, including a neurosurgeon, radiation oncologist and medical physicist, has been treating patients for a variety of brain tumors and vascular disorders in the brain.

Gamma Knife® radiosurgery, a gentler alternative to traditional brain surgery, delivers up to thousands of low-intensity radiation beams to one or more targets with pinpoint accuracy. “Gamma Knife is the accepted gold standard when it comes to radiosurgery in the brain,” says Olof Sandén, Elekta’s Executive Vice President, Europe and AFLAME. “The acquisition of Perfexion by CHUV, together with the center’s extensive radiosurgery experience of CHUV’s Gamma Knife staff, combine to provide the most effective and efficient patient care for serious brain diseases.”

Among the indications CHUV physicians have treated so far have been vestibular schwannomas, meningiomas, pituitary adenomas, a glomus jugular tumor and various other benign and vascular disorders of the brain. In the near future, doctors expect to begin treating patients with secondary cancerous brain tumors (metastases), for which Gamma Knife surgery is often the only practical solution.

“We are excited about this new Gamma Knife program in Switzerland,” Sandén adds. “It offers patients in the entire region a proven and well documented out-patient procedure to effectively treat these conditions.”
 
CHUV treats three to four patients per week during its two weekly radiosurgery days and predicts expanding the service to at least four days, averaging eight patients per week.

With 1,400 inpatient beds and more than 8,000 employees, CHUV is an important European medical center and one of five university hospitals in Switzerland. CHUV provides care in all medical and surgical disciplines on inpatient and outpatient bases and plays a leading role in specialty areas, such as burn care, organ transplantation and cardiology.

CHUV’s Perfexion is among 40 Gamma Knife systems in Europe.

 

###

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.

Press Releases

For further information, please contact

Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37
Email: stina.thorman@elekta.com
Time zone: CET: Central European Time

Michelle Lee Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447
Email: michelle.joiner@elekta.com
Time zone: ET: Eastern Time